Medicare - QuikReader

I’m blindsided by extra Medicare charges because of my income. How do I avoid this situation?

A reader is trying to plan ahead to avoid the dreaded IRMAA, a surcharge that can come out of your Social Security check.

MarketWatch - 50m

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

CNBC - 18h

Ozempic picked for Medicare price bargaining

Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...

The Hill - 19h

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

The Wall Street Journal - 1d

The next 15 drugs chosen for Medicare negotiation

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...

The Hill - 1d

White House says popular weight-loss drug Ozempic subject to Medicare talks

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

MarketWatch - 1d

Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

NBC News - 1d

Ozempic, Wegovy on list for Medicare drug price negotiations

The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

CBS News - 1d

CMS to seek Medicare negotiations on Ozempic price

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...

The Hill - 1d

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

The New York Times - 1d

Biden administration picks 15 more drugs for Medicare negotiation

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...

The Hill - 1d

Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.

CNBC - 2d

‘He threw a book at me’: Why IRMAA surcharges make seniors on Medicare so mad

Letters will go out soon for those who will have to pay extra next year for their Part B and D premiums

MarketWatch - Jan. 11

Corrective action is needed to preserve Social Security, Medicare and Medicaid

Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and Medicaid.

The Hill - Jan. 10

Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds

AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.

CNBC - Jan. 9

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.

CNBC - Jan. 9

Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

NBC News - Jan. 9

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

MarketWatch - Jan. 9

Johnson says no cuts to Social Security and Medicare to fund Trump's agenda

House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out to fund President-elect Donald Trump's agenda.

ABC News - Jan. 7

Here are big changes retirees can expect from Social Security and Medicare in 2025

Retirees can expect to see some big changes in 2025 when it comes to their Social Security and Medicare benefits.

NBC News - Jan. 4

What’s going to happen with Social Security and Medicare in 2025?

What retirees should know about these important benefits heading into the new year.

MarketWatch - Jan. 4

Here are big changes retirees can expect from Social Security and Medicare in 2025

Millions of beneficiaries can expect enhanced Social Security benefits and new limits to Medicare prescription drug costs in 2025.

CNBC - Jan. 4

Sanders gets Finance perch to push Social Security, Medicare expansion, tax reform

Sen. Bernie Sanders (I-Vt.), who supports expanding Social Security and Medicare and raising taxes on the wealthy, will get a seat on the Senate’s powerful Finance Committee, which has jurisdiction ...

The Hill - Jan. 2

Here's what to know about Medicare's new spending cap

This year, a new spending cap on medication goes into effect for the first time for people on Medicare. CBS News medical contributor Dr. Celine Gounder explains its impact.

CBS News - Jan. 2

Latest in Medicare